Eastman Chemical (NYSE: EMN) reported Q4 EPS of $1.51, $0.02 better than the analyst estimate of $1.49. Revenue for the quarter came in at $2.19 billion versus the consensus estimate of $2.14 billion.

For earnings history and earnings-related data on Eastman Chemical (EMN) click here.